Cell Therapeutics, Inc. ("CTI") announced today that it has received notice that the European Medicines Agency ("EMEA") has validated the expanded Pe...
Kibow Biotech would like to show its support for Kidney Disease Awareness and Education Week 2010, organized by American Nephrology Nurses' Association . Kidney Dis...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. physicians will require less cli...
Novavax, Inc. reported today that results from a pre-clinical toxicology study of its vaccine candidate to prevent respiratory syncytial virus , showed the vaccine to be...
Interleukin Genetics, Inc. announced today that the Company has signed an agreement with the University of Michigan to conduct a landmark clinical study on risk factors ...
AdvanDx today announced the launch of its CE-IVD marked GNR Traffic Light PNA FISH® test in Europe. GNR Traffic Light PNA FISH is the first-ever test capable of simultan...
GlaxoSmithKline and Valeant Pharmaceuticals International announced today that a U.S. Food and Drug Administration advisory committee voted unanimously that clinical s...
Amgen today announced top-line results from a randomized Phase 3 trial evaluating Vectibix® as a first-line treatment in patients with recurrent and/or metastatic squam...
NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today that it...
The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.